Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × vorolanib × Clear all

NCT04373369 2025-11-03

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

11 enrolled 10 charts

Small Cell Lung Carcinoma

NCT03904719 2020-07-09

CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)

Phase 2 Unknown

Small Cell Lung Carcinoma